BCAB
Price
$0.50
Change
+$0.06 (+13.64%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
25.98M
9 days until earnings call
DNLI
Price
$16.51
Change
+$0.26 (+1.60%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
2.36B
14 days until earnings call
Ad is loading...

BCAB vs DNLI

Header iconBCAB vs DNLI Comparison
Open Charts BCAB vs DNLIBanner chart's image
BioAtla
Price$0.50
Change+$0.06 (+13.64%)
Volume$2.19K
Capitalization25.98M
Denali Therapeutics
Price$16.51
Change+$0.26 (+1.60%)
Volume$29.8K
Capitalization2.36B
BCAB vs DNLI Comparison Chart
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. DNLI commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Buy and DNLI is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (BCAB: $0.44 vs. DNLI: $16.25)
Brand notoriety: BCAB and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 63% vs. DNLI: 96%
Market capitalization -- BCAB: $28.94M vs. DNLI: $2.4B
BCAB [@Biotechnology] is valued at $28.94M. DNLI’s [@Biotechnology] market capitalization is $2.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAB is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 6 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • BCAB’s TA Score: 6 bullish, 4 bearish.
  • DNLI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than DNLI.

Price Growth

BCAB (@Biotechnology) experienced а +31.28% price change this week, while DNLI (@Biotechnology) price change was +23.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

BCAB is expected to report earnings on Aug 07, 2025.

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.36B) has a higher market cap than BCAB($26M). DNLI YTD gains are higher at: -20.265 vs. BCAB (-24.746). BCAB has higher annual earnings (EBITDA): -85.17M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. BCAB (56.5M). BCAB has less debt than DNLI: BCAB (1.25M) vs DNLI (48.7M). BCAB has higher revenues than DNLI: BCAB (11M) vs DNLI (0).
BCABDNLIBCAB / DNLI
Capitalization26M2.36B1%
EBITDA-85.17M-492.89M17%
Gain YTD-24.746-20.265122%
P/E RatioN/AN/A-
Revenue11M0-
Total Cash56.5M832M7%
Total Debt1.25M48.7M3%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABDNLI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with PDSB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+0.98%
PDSB - BCAB
39%
Loosely correlated
-0.80%
CTMX - BCAB
38%
Loosely correlated
-0.30%
DNLI - BCAB
37%
Loosely correlated
+3.64%
AMLX - BCAB
37%
Loosely correlated
-6.53%
GALT - BCAB
37%
Loosely correlated
N/A
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+3.64%
BEAM - DNLI
58%
Loosely correlated
+1.43%
ARWR - DNLI
58%
Loosely correlated
+2.04%
NTLA - DNLI
57%
Loosely correlated
+2.05%
RCKT - DNLI
56%
Loosely correlated
-0.97%
RGNX - DNLI
56%
Loosely correlated
-0.22%
More